3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
22
Carcinoma, Non-Small-Cell Lung
15
Ovarian Neoplasms
12
Fallopian Tube Neoplasms
11
Carcinoma, Hepatocellular
9
Colorectal Neoplasms
8
Urinary Bladder Neoplasms
7
Pancreatic Neoplasms
7
Melanoma
6
Lymphoma, Large B-Cell, Diffuse
6
Mycosis Fungoides
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Carcinoma, Renal Cell
5
Squamous Cell Carcinoma of Head and Neck
4
Neoplasm Metastasis
4
Lymphoma, T-Cell, Cutaneous
4
Glioblastoma
4
Colonic Neoplasms
4
Breast Neoplasms
4
Triple Negative Breast Neoplasms
3
Thyroid Neoplasms
3
Sezary Syndrome
3
Rectal Neoplasms
3
Nasopharyngeal Carcinoma
3
Multiple Myeloma
3
Mouth Neoplasms
3
Lymphoma, T-Cell
3
Lymphoma, B-Cell
3
Endometrial Neoplasms
3
Cholangiocarcinoma
3
Interventions
Cyclophosphamide
6
Vincristine
3
Temozolomide
3
Radiotherapy
3
Cisplatin
3
Automobiles
3
fludarabine
2
Etoposide
2
Eflornithine
2
Carboplatin
2
omburtamab I-131
1
ibrutinib
1
gallium Ga 68 dotatate
1
etoposide phosphate
1
belzutifan
1
Zoledronic Acid
1
Thiotepa
1
Tamoxifen
1
Standard of Care
1
Radiotherapy, Image-Guided
1
Pemetrexed
1
ONC206
1
Nivolumab
1
Mesna
1
Maintenance Chemotherapy
1
Lomustine
1
Isotretinoin
1
Induction Chemotherapy
1
Hydrocortisone
1
HhAntag691
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive
×
Disulfides
×
1 year
×
Clear all
No trials found.